stats
globeinteractive.com: Making the Business of Life Easier

   Finance globeinvestor   Careers globecareers.workopolis Subscribe to The Globe
The Globe and Mail /globeandmail.com
Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels
space


Search

space
  This site         Tips

  
space
  The Web Google
space
   space



space

  Where to Find It


Breaking News
  Home Page

  Report on Business

  Sports

  Technology

space
Subscribe to The Globe

Shop at our Globe Store


Print Edition
  Front Page

  Report on Business

  National

  International

  Sports

  Arts & Entertainment

  Editorials

  Columnists

   Headline Index

 Other Sections
  Appointments

  Births & Deaths

  Books

  Classifieds

  Comment

  Education

  Environment

  Facts & Arguments

  Focus

  Health

  Obituaries

  Real Estate

  Review

  Science

  Style

  Technology

  Travel

  Wheels

 Leisure
  Cartoon

  Crosswords

  Food & Dining

  Golf

  Horoscopes

  Movies

  Online Personals

  TV Listings/News

 Specials & Series
  All Reports...

space

Services
   Where to Find It
 A quick guide to what's available on the site

 Newspaper
  Advertise

  Corrections

  Customer Service

  Help & Contact Us

  Reprints

  Subscriptions

 Web Site
  Advertise

  E-Mail Newsletters

  Free Headlines

  Globe Store New

  Help & Contact Us

  Make Us Home

  Mobile New

  Press Room

  Privacy Policy

  Terms & Conditions


GiveLife.ca

    

PRINT EDITION
Hexo outlines plan to bring CBD products to U.S. as third-quarter results miss estimates, stock slips
space
space
By ARMINA LIGAYA
THE CANADIAN PRESS
  
  

Email this article Print this article

space  Advertisement
space

Friday, June 14, 2019 – Page B2

Cannabis company Hexo Corp. outlined its plans to enter eight U.S. states with cannabidiol (CBD) products in 2020 as it reported third-quarter earnings that fell short of expectations, sending its stock lower.

Hexo chief executive Sebastien St-Louis would not say which states the cannabis producer was prioritizing, but the company expects to enter the U.S. market through a joint venture with Molson Coors Brewing Co.

He added that it plans to launch a suite of products and is in varying levels of discussion with roughly 60 Fortune 500 companies for potential partnerships.

"We think we can enter with our Fortune 500 partners. ... We think we can lever their existing distribution and go through nonmarijuana channels," he said on a conference call on Thursday.

Cannabis is legal for medical and recreational use in several U.S. states, but remains illegal at the federal level south of the border. However, the passage of a U.S.

law late last year has allowed for the growing of hemp for the purposes of extracting CBD.

Hexo already has a Canadian joint venture with Molson Coors for a portfolio of cannabis-infused beverages, called Truss.

Mr. St-Louis said the company plans to enter the U.S. beverage market with a similar type of partnership with Molson.

Gatineau-based Hexo's U.S. plans came as it reported financial results for its third quarter. During the three months ended April 30, Hexo saw net revenues of $13-million, up from $1.24-million during the same period a year earlier before the legalization of recreational cannabis in Canada last October.

However, its latest quarterly revenues fell short of the $14-million expected by analysts, according to Thomson Reuters Eikon.

Hexo's quarterly net loss deepened to $7.75-million, from a $1.97million loss a year earlier, as operating expenses jumped to $24.1-million from $5.3million during the same period in 2018.

The company's stock on the Toronto Stock Exchange on Thursday slipped as low as $7.78, down 8.8 per cent from $8.53 on Wednesday.

RBC Capital Markets analyst Douglas Miehm said Hexo's results were "a little light" relative to estimates.

"Though, we note that the variance (at least compared to RBCCM) was driven by the company's medical business, with the more important adult-use segment tracking in line with expectations," he said in a note to clients.

Hexo said Thursday that it still expects to ramp its net revenue to $400-million by its 2020 financial year.

However, there are two factors that could put that $400-million target at risk, Mr. St-Louis said. Hexo's Belleville, Ont., facility must be operational by the fall, but the company expects it will be ready in time, he told analysts.

As well, the legalization of edibles and other next-generation cannabis products are expected to be legalized in the coming months, but long delays would push the timing back, Mr. St-Louis said.

Health Canada has completed its consultation on the draft version of the regulations, but has yet to release the final rules.

"It would be prudent to expect a delay, potentially into December," Mr. St-Louis said on the conference call. "But if it's further delayed, that could put upwards of $100million of that $400-million at risk. ... As we're planning advanced products to be about 25 per cent."

Hexo's $400-million revenue guidance does not include its U.S. plans, he noted.

The cannabis company says it has secured a supply of 60,000 kilograms of hemp for extraction of CBD, the compound that can be derived from both cannabis and hemp, in preparation for the coming edibles market and its U.S. launch in 2020. It has also entered into a supply agreement for 200,000 kg of hemp to be supplied during its 2020 financial year.

HEXO (HEXO) CLOSE: $7.81, DOWN 72¢


Huh? How did I get here?
Return to Main Leah_McLaren Page
Subscribe to
The Globe and Mail
 

Email this article Print this article

space  Advertisement
space

Need CPR for your RSP? Check your portfolio’s pulse and lower yours by improving the overall health of your investments. Click here.

Advertisement

7-Day Site Search
    

Breaking News



Today's Weather


Inside

Rick Salutin
Merrily marching
off to war
Roy MacGregor
Duct tape might hold
when panic strikes


Editorial
Where Manley is going with his first budget




space

Columnists



For a columnist's most recent stories, click on their name below.

 National


Roy MacGregor arrow
This Country
space
Jeffrey Simpson arrow
The Nation
space
Margaret Wente arrow
Counterpoint
space
Hugh Winsor  arrow
The Power Game
space
 Business


Rob Carrick arrow
Personal Finance
space
Drew Fagan arrow
The Big Picture
space
Mathew Ingram arrow
space
Brent Jang arrow
Business West
space
Brian Milner arrow
Taking Stock
space
Eric Reguly arrow
To The Point
space
Andrew Willis arrow
Streetwise
space
 Sports


Stephen Brunt arrow
The Game
space
Eric Duhatschek arrow
space
Allan Maki arrow
space
William Houston arrow
Truth & Rumours
space
Lorne Rubenstein arrow
Golf
space
 The Arts


John Doyle arrow
Television
space
John MacLachlan Gray arrow
Gray's Anatomy
space
David Macfarlane arrow
Cheap Seats
space
Johanna Schneller arrow
Moviegoer
space
 Comment


Murray Campbell arrow
Ontario Politics
space
Lysiane Gagnon arrow
Inside Quebec
space
Marcus Gee arrow
The World
space
William Johnson arrow
Pit Bill
space
Paul Knox arrow
Worldbeat
space
Heather Mallick arrow
As If
space
Leah McLaren arrow
Generation Why
space
Rex Murphy arrow
Japes of Wrath
space
Rick Salutin arrow
On The Other Hand
space
Paul Sullivan arrow
The West
space
William Thorsell arrow
space





Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels
space

© 2003 Bell Globemedia Interactive Inc. All Rights Reserved.
Help & Contact Us | Back to the top of this page